J.P. Morgan Maintains Fortis(FTS.US) With Sell Rating, Raises Target Price to $43.44
CIBC Maintains Fortis(FTS.US) With Hold Rating, Raises Target Price to $45.57
RBC Capital Maintains Fortis(FTS.US) With Hold Rating, Raises Target Price to $47.96
Fortis Inc. Is Maintained at Sector Perform by RBC Capital
RBC Capital Maintains Fortis(FTS.US) With Hold Rating, Maintains Target Price $45.88
Fortis Healthcare Target Price Raised to INR588 From INR485 by BNP Paribas Securities India >532843.BY
BMO Capital Maintains Fortis(FTS.US) With Hold Rating, Raises Target Price to $45.97
Maintaining Hold Position on Fortis: Balanced Growth and Valuation Outlook
Fortis Inc Is Maintained at Underperform by Banc of America
Fortis Inc Price Target Is Maintained at C$60.00/Share by Banc of America
BofA Securities Maintains Fortis(FTS.US) With Sell Rating, Raises Target Price to $44.17
UBS Raises Price Target on Fortis to CA$59 From CA$50, Maintains Sell Rating
BMO Capital Maintains Fortis(FTS.US) With Hold Rating, Raises Target Price to $45.18
BMO Capital Reaffirms Their Hold Rating on Fortis (FTS)
Fortis Inc Price Target Raised to C$61.00/Share From C$59.00 by BMO Capital Markets
National Bank Maintains Fortis(FTS.US) With Hold Rating, Raises Target Price to $45.84
Scotiabank Maintains Fortis(FTS.US) With Hold Rating, Raises Target Price to $46.26
Scotiabank Maintains Sector Perform on Fortis, Raises Price Target to C$63
Jefferies Adjusts Fortis Healthcare's Price Target to INR575 From INR545, Keeps at Buy
BMO Capital Maintains Fortis(FTS.US) With Hold Rating, Raises Target Price to $42.54